Evidence map›Paper›PMID 22163007›Full record

ArticlePloS one2011

MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex.

Andriy E Belevych, Sarah E Sansom, Radmila Terentyeva, Hsiang-Ting Ho, Yoshinori Nishijima, Mickey M Martin, Hitesh K Jindal, Jennifer A Rochira, Yukiko Kunitomo, Maha Abdellatif and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Loss of protein phosphatase 2A regulatory subunitFrontiers in cardiovascular medicine · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Exosomes in Cardiovascular Diseases.Diagnostics (Basel, Switzerland) · 2020
    Review
  19. Review
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Andriy E BelevychThe Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America.
Sarah E Sansom
Radmila Terentyeva
Hsiang-Ting Ho
Yoshinori Nishijima
Mickey M Martin
Hitesh K Jindal
Jennifer A Rochira
Yukiko Kunitomo
Maha Abdellatif
Cynthia A Carnes
Terry S Elton
Sandor Györke
Dmitry Terentyev
The Ohio State University · USRhode Island Hospital · USBrown University · USRutgers, The State University of New Jersey · US

Funding

CONTROLLED AND UNCONTROLLABLE CALCIUM RELEASE IN HEARTR01HL063043 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI Sandor Gyorke · 1999 to 2026
$8.6M
Ryanodine Receptor Channels in Heart FailureR01HL074045 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GYORKE, SANDOR · 2003 to 2024
$8.2M
Brown CardioPulmonary Research Training ProgramT32HL094300 · NHLBI · RHODE ISLAND HOSPITAL · PI KOREN, GIDEON · 2008 to 2012
$2.2M
HUMAN ANGIOTENSIN II RECEPTOR GENE REGULATIONR01HL048848 · NHLBI · OHIO STATE UNIVERSITY · PI ELTON, TERRY S · 1997 to 2009
$2.1M
Heart Failure and Atrial FibrillationR01HL089836 · NHLBI · OHIO STATE UNIVERSITY · PI CARNES, CYNTHIA A · 2008 to 2012
$2.1M
microRNA and Down SyndromeR21HD058997 · NICHD · OHIO STATE UNIVERSITY · PI ELTON, TERRY S, OBRIETAN, KARL H · 2009 to 2010
$429k
ANGIOTENSIN II RECEPTOR GENE EXPRESSIONR29HL048848 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ELTON, TERRY S · 1992 to 1996
–
NHLBI NIH HHS 5T32HL094300NHLBI NIH HHS HL048848NHLBI NIH HHS HL063043NHLBI NIH HHS HL074045NHLBI NIH HHS HL089836NHLBI NIH HHS R01 HL048848NHLBI NIH HHS R01 HL063043NHLBI NIH HHS R01 HL074045NHLBI NIH HHS R01 HL089836NHLBI NIH HHS R29 HL048848NHLBI NIH HHS T32 HL094300NICHD NIH HHS HD058997NICHD NIH HHS R21 HD058997
6 · The paper itself

Abstract

In heart failure (HF), arrhythmogenic spontaneous sarcoplasmic reticulum (SR) Ca(2+) release and afterdepolarizations in cardiac myocytes have been linked to abnormally high activity of ryanodine receptors (RyR2s) associated with enhanced phosphorylation of the channel. However, the specific molecular mechanisms underlying RyR2 hyperphosphorylation in HF remain poorly understood. The objective of the current study was to test the hypothesis that the enhanced expression of muscle-specific microRNAs (miRNAs) underlies the HF-related alterations in RyR2 phosphorylation in ventricular myocytes by targeting phosphatase activity localized to the RyR2. We studied hearts isolated from canines with chronic HF exhibiting increased left ventricular (LV) dimensions and decreased LV contractility. qRT-PCR revealed that the levels of miR-1 and miR-133, the most abundant muscle-specific miRNAs, were significantly increased in HF myocytes compared with controls (2- and 1.6-fold, respectively). Western blot analyses demonstrated that expression levels of the protein phosphatase 2A (PP2A) catalytic and regulatory subunits, which are putative targets of miR-133 and miR-1, were decreased in HF cells. PP2A catalytic subunit mRNAs were validated as targets of miR-133 by using luciferase reporter assays. Pharmacological inhibition of phosphatase activity increased the frequency of diastolic Ca(2+) waves and afterdepolarizations in control myocytes. The decreased PP2A activity observed in HF was accompanied by enhanced Ca(2+)/calmodulin-dependent protein kinase (CaMKII)-mediated phosphorylation of RyR2 at sites Ser-2814 and Ser-2030 and increased frequency of diastolic Ca(2+) waves and afterdepolarizations in HF myocytes compared with controls. In HF myocytes, CaMKII inhibitory peptide normalized the frequency of pro-arrhythmic spontaneous diastolic Ca(2+) waves. These findings suggest that altered levels of major muscle-specific miRNAs contribute to abnormal RyR2 function in HF by depressing phosphatase activity localized to the channel, which in turn, leads to the excessive phosphorylation of RyR2s, abnormal Ca(2+) cycling, and increased propensity to arrhythmogenesis.

Indexed as

AnimalsArrhythmias, CardiacCalciumCatalysisCatalytic DomainDogsElectrophysiologyGenes, ReporterHeart FailureHeart VentriclesHumansIsoproterenolMicroRNAsModels, BiologicalMuscle CellsPhosphoric Monoester HydrolasesCalciumIsoproterenolMicroRNAsMIRN133 microRNA, humanMIRN1 microRNA, humanPhosphoric Monoester HydrolasesReceptors, Adrenergic, betaRNA, MessengerRyanodine Receptor Calcium Release Channel

Identifiers

PMID22163007
PMCPMC3232211
OpenAlexW2069569950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.